Evidence for widespread epithelial damage and coincident production of monocyte chemotactic protein 1 in a murine model of intestinal ricin intoxication.
The development of small-animal models is necessary to understand host responses and immunity to emerging infectious diseases and potential bioterrorism agents. In this report we have characterized a murine model of intestinal ricin intoxication. Ricin administered intragastrically (i.g.) to BALB/c mice at doses ranging from 1 to 10 mg/kg of body weight induced dose-dependent morphological changes in the proximal small intestine (i.e., duodenum), including widespread villus atrophy and epithelial damage. Coincident with epithelial damage was a localized increase in monocyte chemotactic protein 1, a chemokine known to be associated with inflammation of the intestinal mucosa. Immunity to intestinal ricin intoxication was achieved by immunizing mice i.g. with ricin toxoid and correlated with elevated levels of antitoxin mucosal immunoglobulin A (IgA) and serum IgG antibodies. We expect that this model will serve as a valuable tool in identifying the inflammatory pathways and protective immune responses that are elicited in the intestinal mucosa following ricin exposure and will prove useful in the evaluation of antitoxin vaccines and therapeutics.
Yoder
J Marina
JM
Division of Infectious Disease, Wadsworth Center, New York State Department of Health, 120 New Scotland Avenue, Albany, NY 12208, USA.
Aslam
Rabia U
RU
Mantis
Nicholas J
NJ
D000818:Animals; D000992:Antitoxins / Q000032:analysis / Q000097:blood; D018932:Chemokine CCL2 / Q000096:biosynthesis*; D004195:Disease Models, Animal; D004386:Duodenum / Q000473:pathology; D004847:Epithelial Cells / Q000187:drug effects*; D005260:Female; D006651:Histocytochemistry; D007114:Immunization; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000097:blood; D007413:Intestinal Mucosa / Q000276:immunology / Q000378:metabolism / Q000473:pathology*; D051379:Mice; D008807:Mice, Inbred BALB C; D011041:Poisoning / Q000276:immunology / Q000473:pathology*; D012276:Ricin / Q000276:immunology / Q000506:poisoning*; D014121:Toxoids / Q000008:administration & dosage / Q000276:immunology
D000992:Antitoxins; D018932:Chemokine CCL2; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D014121:Toxoids; D012276:Ricin